Olga Pavlovna Parshina

Ms. Olga Pavlovna Parshina

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Anastasiia BuianovaAnastasiia Buianova
Anastasiia Buianova
YLYulia S. Lashkova
Yulia S. Lashkova
TKTatiana V. Kulichenko
Tatiana V. Kulichenko
IKIvan S. Kuznetsov
Ivan S. Kuznetsov
AIArtem A. Ivanov
Artem A. Ivanov
DKDmitriy Korostin
Dmitriy Korostin
This study reports a 14-year-old male patient with multiple congenital anomalies, including hypospadias, complete cleft palate, and recurrent pneumonia. His clinical presentation includes significant physical and intellectual developmental delays, autism-like symptoms, and spastic diplegia. Whole-exome sequencing (WES) was performed due to these complex symptoms, revealing a novel heterozygous deletion on chromosome 10q24.31-q24.33. Laboratory findings indicated agammaglobulinemia, leading to prophylactic antibiotic therapy and immunoglobulin replacement. Additional imaging studies showed cystic malformation of the middle lobe of the right lung, sliding hiatal hernia with prolapse of the gastric mucosa, and brain anomalies consistent with Joubert syndrome. This case underscores the importance of genetic analysis in understanding the etiology of congenital anomalies and neurodevelopmental disorders, demonstrating that WES can provide critical insights into the genetic basis of complex clinical presentations. The identified chromosomal deletion contributes to the existing literature on genomic imbalances associated with similar phenotypes.

30 December 2025 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
Anastasiia BuianovaAnastasiia Buianova
Anastasiia Buianova
ARA. V. Rozhkova
A. V. Rozhkova
OPOlga Pavlovna Parshina
Olga Pavlovna Parshina
AKA. A. Kudakaeva
A. A. Kudakaeva
EVEvgeny Vasilyev
Evgeny Vasilyev
ENE. A. Nikolaeva
E. A. Nikolaeva
X-linked dominant hypophosphatemic rickets is the most common inherited form of hypophosphatemic rickets, characterized by renal dysfunction, skeletal deformities, and other multi-organ complications. In Russia, since 2022, the first targeted therapy has been approved for clinical use — Burosumab, a monoclonal antibody directed against fibroblast growth factor 23. Initiation of treatment requires confirmation of the diagnosis through molecular genetic testing. This study presents two clinical case reports of patients with X-linked dominant hypophosphatemic rickets. The clinical diagnosis was established at the ages of 7 and 12 years based on a characteristic biochemical profile and radiographic findings. However, causative variants in the PHEX gene (c.2147+1197A>G and chrX:22030553_22033026del) were identified only after whole-genome sequencing, followed by detailed analysis of next-generation sequencing data.